Science2 days ago
FDA Provides Positive Feedback for Tharimmune’s Controversial Drug
The U.S. Food and Drug Administration (FDA) has recently issued positive feedback regarding a new drug developed by the cryptocurrency company Tharimmune Inc. The drug, known...
